Weight maintenance

Exercise and liraglutide after weight loss: the S-LiTE trial

S-LiTE studied maintenance after an intensive diet. Exercise and liraglutide had different roles, and the combined weight result needs its statistical qualifier.

Editorial analysis · Not a clinical consultation

In this article
Running shoes, a closed exercise diary and a jacket on a park bench illustrate the practical routine of activity maintenance.
Illustrative exercise still life; not study equipment, a participant or a measured weight-maintenance result.

What to know

  • The trial began after an intensive diet and initial weight loss.
  • Combined treatment did not significantly beat liraglutide alone on the primary weight comparison.
  • Post-treatment findings come from a smaller returning subset of the same trial.

Maintenance deserves its own plan

Losing weight and maintaining that change are different tasks. S-LiTE studied what happened after adults had already completed a demanding initial diet, then received exercise support, liraglutide, both, or placebo for a year. [1] It is a useful experiment for someone wondering how physical activity and medication might fit together. It does not show that a person must reproduce a research diet to deserve support, or that every fitness subscription can deliver the same outcome. The practical lesson begins with planning the next phase. A service should explain how support continues once the initial change slows, rather than treating maintenance as something that happens automatically after a successful starting period.

The starting point was selected by a diet run-in

The original protocol specified an eight-week, 800-calorie daily diet and at least 5% weight loss before randomization. Adults were 18–65 years old with an initial BMI of 32–43. The planned exercise target was 150 minutes weekly, and the drug regimen was daily subcutaneous liraglutide 3.0 mg. [2] These details describe a supervised experiment, not a home diet or dosing recommendation. They also mean the randomized question started after an initial response to intensive restriction. The outcome cannot be applied unchanged to everyone starting treatment, people with diabetes, or someone joining a general exercise app without that clinical and research setting.

The weight result has an important qualifier

After the diet, 195 participants had lost an average 13.1 kg. At one year, the combination group had a 9.5 kg more favorable weight change than placebo, 5.4 kg more favorable than exercise alone, and 2.7 kg more favorable than liraglutide alone. The last difference was not statistically significant: its 95% confidence interval ranged from 6.3 kg in favor of combination to 0.8 kg in the other direction. [1] That matters. The study supports a favorable combination strategy, but it does not establish superiority over liraglutide alone for this weight endpoint. A clear explanation keeps that uncertainty visible while allowing other outcomes to contribute to the decision.

The exercise was more than generic advice

The published trial describes a six-week ramp-up, followed by encouragement to attend two supervised weekly sessions combining interval cycling and circuit training, plus two individual moderate-to-vigorous sessions. [3] That is a substantial support arrangement. A remote coach, walking group or workout library may be useful without reproducing it. When comparing services, ask what the person actually receives: session frequency, progression, adaptation and help when a normal week becomes difficult. The research should make those practical differences easier to see. It should not be borrowed as proof that any program with the word exercise in its description will generate the same result.

Body composition adds another useful outcome

The combination reduced body-fat percentage more than either active approach alone, and the original report assessed fitness and metabolic outcomes as well as body weight. Increased heart rate and gallstones were observed more often with liraglutide alone than with combination treatment. [1] These results do not establish that exercise removes medication risks, nor should body-fat percentage replace how someone feels and functions. They show why a maintenance discussion can reasonably include several outcomes. A person who becomes more capable in daily activity may value that progress alongside the scale. The clinician can help distinguish useful measured change from a promise that one routine will prevent all treatment problems.

The year after treatment gives a different view

A follow-up invited all randomized participants back one year after active treatment ended. Of the 166 who completed the maintenance phase, 109 attended the post-treatment assessment. Previous combination treatment showed a 5.1 kg more favorable weight change from randomization than previous liraglutide alone, with a wide confidence interval of 0.2–10.0 kg. [4] This is follow-up from the same trial, not a second randomized experiment. The attendance gap also matters. It supplies a promising view of durability while leaving uncertainty about people who did not return. The result should encourage discussion about ongoing support, rather than imply that a year of exercise guarantees permanent maintenance.

Do not turn follow-up into a stopping instruction

Treatment ended as part of the research design. That does not tell an individual when to stop a prescribed medicine or prove an exercise program can replace it. The follow-up involved liraglutide and a specific supervised exercise arrangement; it does not establish the same transition for semaglutide, tirzepatide or a compounded product. [4] A real maintenance plan needs room for affordability, tolerability, preferences and changes in health. If continued treatment becomes difficult, the useful question is who helps plan the transition and monitor what follows. Ending support at the same time as a prescription can leave precisely the practical gap that maintenance research asks us to take seriously.

Choose support that can survive an ordinary week

S-LiTE gives a reason to discuss physical activity as part of maintenance rather than as punishment for eating or a test of commitment. It also shows why a headline needs the actual comparison and support schedule attached. If a coach is being considered, compare how sessions are adapted, what happens when attendance slips and whether the plan works alongside medical care. If medication is involved, the prescriber should remain part of that conversation. A workable maintenance arrangement can include several kinds of help. The goal is a clear plan that respects the evidence and the person using it, with enough continuing contact to adjust when life changes.

Sources

  1. S-LiTE original randomized maintenance trial (opens in a new tab)
  2. S-LiTE original published protocol (opens in a new tab)
  3. S-LiTE original trial full publication: exercise schedule (opens in a new tab)
  4. S-LiTE post-treatment original follow-up (opens in a new tab)

Research describes groups and specific study conditions. Your medical history, symptoms and treatment decisions require advice from your own qualified clinician.

Keep exploring.

Research library
Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.